Researchers observed that only 8.3% of 24 children or adolescents with peanut allergy passed a double-blind placebo-controlled food challenge with at least 444 mg of peanut protein after receiving ...
13h
GlobalData on MSNSanofi increases ownership stake partaking in pharma buyback trendSanofi has agreed to purchase its own shares worth €2bn ($2.08bn), part of a $5.1bn share buyback initiative in 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results